Keywords
Antisynthetase syndrome, interstitial lung disease, polymyositis/dermatomyositis, idiopathic inflammatory myopathy, mycophenolate mofetil, Rituximab, corticosteroids.
Abstract
A patient with antisynthetase syndrome with pulmonary and muscular involvement was treated with immunosuppressive agents without corticosteroids. Rituximab was added to mycophenolate mofetil therapy with improvement in lung functional and imaging findings and normalization of creatine kinase levels.
References
Views: 744
HTML downloads: 133
PDF downloads: 340
Published:
2022-07-18
Issue:
2022: Vol 9 No 7
(view)